The Prevalence, Characteristics, and Factors Associated with Chinese Herbal Medicine Use Among Chinese Middle-Aged and Older Adults with Chronic Lung Disease: A Cross-Sectional Study
Hui Tian,Xiaorong Zhu,Hongwang Liu,Yangfang Liao,Kaiwang Cui,Jianping Liu,Xiangwen Gong
DOI: https://doi.org/10.2147/jmdh.s478120
2024-11-28
Journal of Multidisciplinary Healthcare
Abstract:Hui Tian, &ast Xiaorong Zhu, &ast Hongwang Liu, Yangfang Liao, Kaiwang Cui, Jianping Liu, Xiangwen Gong Department of Respiratory and Critical Care Medicine, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, the Fifth People's Hospital of Ganzhou, Ganzhou, Jiangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiangwen Gong; Jianping Liu, Department of Respiratory and Critical Care Medicine, The Fifth People's Hospital of Ganzhou, Dongjiangyuan Road 666, Zhanggong District, Ganzhou, Jiangxi Province, 341000, People's Republic of China, Email ; Purpose: Identifying factors that influence Chinese herbal medicine (CHM) use in chronic lung disease (CLD) patients can inform targeted strategies to boost CHM use. However, the prevalence and factors affecting CHM use for treating CLD in middle-aged and older Chinese patients remain understudied. This study aims to examine the prevalence and influencing factors of CHM use among middle-aged Chinese patients with CLD. Patients and Methods: The data analyzed in this study were extracted from the China Health and Retirement Longitudinal Study in 2018. A cross-sectional analysis of 2784 participants aged 45 years and older taking CHM for CLD was included, and influencing factors (demographic characteristics, health status, and healthcare service use) predicting the use of CHM for CLD were identified through multivariate logistic regression model. Results: The prevalence of using CHM to treat CLD was 22.4% (624/2784). Compared to participants with CLD who did not use CHM, those with CLD who used CHM were more likely to be female, and non-smoking, non-drinking, purchased insurance (OR=2.35; 95% CI=1.09, 5.04), went to a traditional Chinese medicine hospital (OR=3.5; 95% CI=1.96, 6.25) and self-treatment (OR=1.67; 95% CI=1.33, 2.10), the health status being poor (OR =1.74; 95% Cl=1.18, 2.56), asthma (OR=1.55; 95% Cl=1.16, 2.09) and depression (OR =1.42; 95% Cl=1.14, 1.75). In the additive interaction analysis, patients who tend to self-medicate and with depression were most likely to use CHM (OR=2.52; 95% Cl=1.85, 3.42). Conclusion: A considerable middle-aged and older Chinese patient with CLD uses CHM for treatment. Multiple factors can influence CHM use, particularly self-treatment and depression. Keywords: influencing factors, Chinese herbal medicine, chronic lung disease, Chinese, middle-aged and older adults, cross-sectional study Chronic lung disease (CLD), including chronic bronchitis, chronic obstructive pulmonary disease (COPD), asthma, pneumoconiosis, interstitial lung disease, and pulmonary fibrosis, are characterized by impaired lung function. These diseases accounted for over 4 million deaths worldwide, which represented 7% of all deaths in 2017. 1 Over the past three decades, the total number of deaths related to CLD has risen by 18.0%. 2 Tobacco use and air pollution, with smog, vehicle emissions and industrial pollution being among the most serious environmental and public health problems in today's industrialized nations, 3,4 are main causes leading to damage to the bronchial and alveolar tissues, ultimately resulting in respiratory dysfunction. 5 This problem has also become more prominent in China as industrialization accelerating in low- and middle-income countries. Studies have shown that middle-aged and older people are more vulnerable to the effects of air pollution than younger people. 6,7 Thus, CLD in the middle-aged and above patients should be play more attention. Chinese herbal medicine (CHM) has been used for centuries to prevent and treat CLD. Ancient medical documents, such as the Shennong Ben Cao Jing and Shang Han Lun, comprehensively recorded traditional Chinese medicine (TCM) theories such as resolving phlegm, alleviating coughs, and calming wheezing, along with numerous prescriptions for treating CLD. It is reported that more than 80% of people in developing countries rely on CHM for treatment of diseases. 8 According to China's National Bureau of Statistics, the value of industrial output from TCM reached USD$68 billion (RMB418 billion) in 2011 with an annual growth rate of 37.9%. 9 This shows that the value of Chinese medicine is increasingly recognized. Generally speaking, TCM prescriptions are usually composed of two or more kinds of CHM. These prescriptions are based on thousands of years of clinical application and modern research of Chinese medicine. At present, hundreds of CHM have shown good curative effects in the treatment of pneumonia, asthma, CLD and lung cancer. The realization of curative effects mainly depends on the bioactive compounds or -Abstract Truncated-
health care sciences & services